Comments
Loading...
Nkarta (NASDAQ:NKTX) Stock Quotes, Forecast and News Summary
Nkarta Stock (NASDAQ: NKTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nkarta (NKTX) stock?
You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.
Who are Nkarta (NKTX) competitors?
Other companies in Nkarta’s space includes: Molecular Partners (NASDAQ:MOLN), Galectin Therapeutics (NASDAQ:GALT), Atossa Therapeutics (NASDAQ:ATOS), Kyverna Therapeutics (NASDAQ:KYTX) and Eledon Pharma (NASDAQ:ELDN).
What is the forecast, or price target, for Nkarta (NKTX) stock?
Nkarta has a consensus price target of $20.44.
What is the current price for Nkarta (NKTX)?
The stock price for Nkarta (NASDAQ: NKTX) is $2.475 last updated November 18, 2024 at 2:07 PM EST.
Does Nkarta (NKTX) pay a dividend?
There are no upcoming dividends for Nkarta.
When is Nkarta (NASDAQ:NKTX) reporting earnings?
Nkarta’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Nkarta (NKTX) going to split?
There is no upcoming split for Nkarta.
What sector and industry does Nkarta (NKTX) operate in?
Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.